Skip to content

Identification of miRNAs as serum markers for the treatment effect of panic disorder

Identification of miRNAs as serum markers for the treatment effect of panic disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROB-17013747
Enrollment
Unknown
Registered
2017-12-06
Start date
2017-12-31
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

panic disorder

Interventions

case group:treatment with sertraline

Sponsors

the People's Hospital of Sichuan Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) aged 18-55 years old; 2) fulfilling the Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV) criteria for PD; 3) with a minimum 14- item Hamilton Anxiety Rating Scale (HAMA-14) score at 14; 4) without any anti-anxiety medication for at least two weeks or fluoxetine for four weeks; 5) without any hormone treatment; 6) without use of oral contraceptives for female patients.

Exclusion criteria

Exclusion criteria: Patients with other Axis I psychiatric disorders including bipolar disorder, dementia, schizophrenia, substance abuse, et al, or with Axis II disorders including personality disorders, and those with any history of major medical/neurological disorders ,and pregnancy.

Design outcomes

Primary

MeasureTime frame
Plasma miRNA;

Countries

China

Contacts

Public ContactSun Xueli

Mental Health Center, West China University Hospital, Sichuan University

jiaojiao1766@163.com+86 17708130593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026